Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

UK ministers ‘picking number out of air’ for civil service job cuts, says union

Headcount reduction of 90,000 civil servants is ‘unrealistic’ and poor way to manage government, says FDA union chief

The Guardian - UK · May 13, 2022

US parents swap and sell baby formula amidst country-wide shortage

A US-wide baby formula shortage forces frenzied parents into online groups to swap and sell to each other to keep their babies fed.

ABC News · May 13, 2022

Efficiency minister denies proposed Civil Service cuts are a return to austerity

The Prime Minister was understood to have told his Cabinet on Thursday that the service should be slashed by a fifth.

The Independent UK · May 13, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Editorial: A looming battle over abortion pills threatens cherished freedoms

Following the leak of a draft majority opinion, expectations run high that the U.S. Supreme Court soon will overturn the 1973 Roe v. Wade decision affirming the constitutional right of women to abortion, and we have an idea of what abortion foes will target thereafter: pills.

Chicago Tribune · May 13, 2022

Boris Johnson to slash thousands of civil service jobs as PM is accused of letting workers down

The Prime Minister has been repeatedly accused of failing to do enough to tackle the cost of living crisis.

Daily Record · May 13, 2022

Boris Johnson's plan to axe 91,000 civil service jobs branded 'reckless slash and burn'

Boris Johnson told top Tories to cut the number of Whitehall officials by a fifth as he desperately scrambles to free up cash to ease cost of living pressures

Daily Mirror · May 13, 2022

Boris Johnson wants to cut civil service jobs back to pre-Brexit levels

BORIS Johnson wants to slash the civil service to its pre-Brexit levels by cutting as many as 90,000 people from the government payroll.

The National (Scotland) · May 13, 2022

Read news from The Economist, FT, and more,
with one subscription

Boris Johnson to axe 90,000 civil service jobs to free cash for tax cuts

The move would reduce Government office staff by 20%

Wales Online · May 13, 2022

Jacob Rees-Mogg defends plan to cut 90,000 civil servant jobs

The Prime Minister hinted the money saved by cutting the Civil Service by a fifth could be used for tax cuts

Evening Standard · May 13, 2022

Senator says Biden should consider Defense Production Act to boost baby formula supply

Regular and specialized baby formulas have been running low across the U.S. Sen. Kirsten Gillibrand says she will ask President Biden to consider using the Defense Production Act to boost production.

WEKU · May 12, 2022

HC Wainwright Says This Stock Is Well Capitalized For Value Realization Of Pipeline, Despite COVID-19 Uncertainty

Given the uncertainty, HC Wainwright moderated its COVID-19 franchise estimates, the primary driver of estimate reductions, and price target reduction to $125 (from $200) on Vir Biotechnology Inc (NASDAQ:VIR). The analyst maintained a Buy rating on VIR shares. The analyst continues to view Vir's platform, validated with successful antiviral therapies against Ebola and COVID-19, and pipeline,…

Benzinga · May 12, 2022

Company says it could restart production of baby formula within weeks amid severe shortage

Joe Biden set to discuss the issue and ways to address the shortage with manufacturers

The Independent UK · May 12, 2022

LOCALIZE IT: Ideas for local coverage of baby formula crisis

Parents across the U.S. are scrambling to find baby formula because supply disruptions and a massive safety recall have swept many leading brands off store shelves.

The Independent UK · May 12, 2022

EXPLAINER: What's behind the baby formula shortage?

Many parents are hunting for infant formula after a combination of short- and long-term problems hit the biggest U.S. brands

The Independent UK · May 12, 2022

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga · May 12, 2022

Senators Cory Booker And Brian Schatz Call On Federal Agencies To Research Psychedelics

Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the FDA whom they called on to study the therapeutic potent

Mic · May 12, 2022

These F.D.A. approved underwear protect against STIs

Who are they for, exactly?

Benzinga · May 12, 2022

COCP: Cocrystal Pharma Releases 2022 1st Quarter Results and Provides an Update on the Current Pipeline Programs

By Thomas Kerr, CFA NASDAQ:COCP READ THE FULL COCP RESEARCH REPORT

Benzinga · May 12, 2022

58 Stocks Moving In Thursday's Mid-Day Session

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga · May 12, 2022

Moderna Concludes FDA Submission For Its COVID-19 Shot In Adolescents, Kids

Reuters reported that Moderna Inc (NASDAQ:MRNA) had made required submissions to the FDA for emergency use authorization of its COVID-19 vaccine in adolescents and children. An advisory panel of experts to the U.S. drug regulator will meet in June to review the request. Related: FDA Sets Review Dates For Pfizer, Moderna COVID-19 Shot For…

The Independent UK · May 12, 2022

Biden to speak to baby formula manufacturers about shortage

President Joe Biden plans to speak on Thursday with baby formula manufacturers and retailers about the plight of families struggling to find formula due to supply chain disruptions and a safety recall

Benzinga · May 12, 2022

Protara Therapeutics Shares Retrospective Analysis Of OK-432 In Rare Lymphatic Malformations

Protara Therapeutics Inc (NASDAQ:TARA) announced the results of a retrospective analysis of OK-432, the originator compound for TARA-002, its investigational therapy in development for lymphatic malformations (LMs), rare, congenital malformations of lymphatic vessels. The results from the analysis showed that OK-432 was clinically successful and generally well-tolerated in the treatment of both macrocystic…

Benzinga · May 12, 2022

Rockwell Medical Submits Additional Data For IND Application For Iron Deficiency Candidate

Rockwell Medical Inc (NASDAQ:RMTI) has provided the FDA with the supplemental data requested by the agency in December 2021 for its pending Investigational New Drug (IND) application of Ferric Pyrophosphate Citrate (FPC) for iron deficiency. The IND supports the proposed Phase 2 trial of FPC for treating iron deficiency anemia and maintaining hemoglobin…

Benzinga · May 12, 2022

Stealth BioTherapeutics Shares Rally following FDA Orphan Drug Designation To Elamipretide For Duchenne muscular dystrophy (DMD)

Stealth BioTherapeutics Corp (NASDAQ: MITO) received Orphan Drug Designation to Elamipretide from the United States Food and Drug Administration (FDA) for the treatment of patients with Duchenne muscular dystrophy (DMD).

Benzinga · May 12, 2022

The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga · May 12, 2022

28 Stocks Moving in Thursday's Pre-Market Session

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 89.7% to $0.1480 in pre-market trading after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.

1 … 285 286 287 288

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

National Institutes of Health

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.